Bright Minds Biosciences Inc. (DRUG) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Bright Minds Biosciences Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -47.49x | -2.43x | -1.10x | -1.40x | -9.39x | -95.85x |
| P/B Ratio | 7.08x | 1.23x | 1.22x | 1.99x | 4.19x | 63.14x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 36.10x | 11.32x | 24.26x | 8.11x | 31.38x | 5.82x |
| Quick Ratio | 36.10x | 11.32x | 24.26x | 8.11x | 31.38x | 5.82x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.02x | 0.01x | 0.01x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..